Literature DB >> 6100805

Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma.

M E McLaughlin, I E Liener, N Wang.   

Abstract

Eighteen clones of a methylcholanthrene-induced murine fibrosarcoma (3AM) which were heterogeneous with respect to metastatic potentials and in vivo growth rates were examined for five different protease activities: acid protease (cathepsin D), BANA hydrolase (cathepsin B), neutral protease, collagenase, and plasminogen activator. Homogenates of the solid tumors produced by the clones were heterogeneous with respect to the activities of the proteases; these activities were in all cases (except plasminogen activator) higher than those obtained for normal muscle tissue. There was, however, no correlation between any of these protease activities and the metastatic potential or in vivo growth rates. The cathepsin B activity has also been evaluated on the cultured cells of the various clones. Results similar to that of the in vivo study were obtained. Analysis of the enzyme activity of the cell culture and of organ culture media, however, revealed no cathepsin B activity. It is concluded that the measurement of any one biochemical parameter such as proteolysis may not be sufficient to establish a correlation with the overall process of metastasis; a more precise dissection of the individual steps culminating in metastasis may provide a more fruitful approach to this problem.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6100805     DOI: 10.1007/bf00121198

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  43 in total

1.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Evidence for the presence of a trypsin inhibitor within rabbit and mouse tumour cells.

Authors:  F S Steven; V Podrazky; S Itzhaki
Journal:  Biochim Biophys Acta       Date:  1977-07-08

3.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

4.  Collagenolytic activities of squamous cell carcinoma of the skin.

Authors:  K Hashimoto; Y Yamanishi; E Maeyens; M K Dabbous; T Kanzaki
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Immunofluorescent studies on the occurrence of cathepsin B1 at tumor cell surfaces.

Authors:  B Sylvén; O Snellman; P Sträuli
Journal:  Virchows Arch B Cell Pathol       Date:  1974

6.  A new assay for cathepsin B1 and other thiol proteinases.

Authors:  A J Barrett
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

7.  Inhibition by alpha-macroglobulin and other serum proteins.

Authors:  P M Starkey; A J Barrett
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

Review 8.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.

Authors:  B F Sloane; K V Honn; J G Sadler; W A Turner; J J Kimpson; J D Taylor
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

10.  Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation.

Authors:  P A Jones; W E Laug; W F Benedict
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

View more
  2 in total

Review 1.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

2.  Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines.

Authors:  S Taniguchi; T Iwamura; T Katsuki
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.